Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$19.02 - $30.13 $3.63 Million - $5.75 Million
-190,919 Reduced 95.02%
10,000 $222,000
Q3 2023

Nov 14, 2023

SELL
$30.46 - $46.04 $3.75 Million - $5.66 Million
-122,949 Reduced 37.96%
200,919 $6.12 Million
Q2 2023

Aug 04, 2023

BUY
$31.57 - $37.73 $3.69 Million - $4.41 Million
116,935 Added 56.51%
323,868 $17.1 Million
Q1 2023

May 15, 2023

SELL
$29.72 - $41.45 $3.71 Million - $5.17 Million
-124,836 Reduced 37.63%
206,933 $10.6 Million
Q4 2022

Feb 03, 2023

BUY
$30.23 - $38.71 $4.4 Million - $5.64 Million
145,660 Added 78.27%
331,769 $11.8 Million
Q3 2022

Oct 21, 2022

SELL
$22.51 - $38.27 $2.47 Million - $4.2 Million
-109,705 Reduced 37.09%
186,109 $5.42 Million
Q2 2022

Jul 28, 2022

BUY
$20.97 - $37.47 $2.67 Million - $4.77 Million
127,224 Added 75.46%
295,814 $6.63 Million
Q1 2022

May 12, 2022

SELL
$34.38 - $65.77 $133,669 - $255,713
-3,888 Reduced 2.25%
168,590 $6.22 Million
Q4 2021

Feb 07, 2022

BUY
$63.78 - $97.86 $4.51 Million - $6.92 Million
70,693 Added 69.45%
172,478 $12.2 Million
Q3 2021

Oct 06, 2021

BUY
$45.58 - $88.24 $1.03 Million - $2 Million
22,671 Added 28.66%
101,785 $16.2 Million
Q2 2021

Jul 06, 2021

SELL
$34.4 - $48.34 $1.22 Million - $1.72 Million
-35,485 Reduced 30.96%
79,114 $7.49 Million
Q1 2021

Apr 07, 2021

SELL
$23.17 - $38.3 $214,901 - $355,232
-9,275 Reduced 7.49%
114,599 $8.29 Million
Q4 2020

Feb 01, 2021

SELL
$18.28 - $23.85 $22,393 - $29,216
-1,225 Reduced 0.98%
123,874 $5.88 Million
Q3 2020

Oct 15, 2020

SELL
$12.91 - $18.51 $4,531 - $6,497
-351 Reduced 0.28%
125,099 $4.53 Million
Q2 2020

Jul 22, 2020

BUY
$9.68 - $17.5 $1.21 Million - $2.2 Million
125,450 New
125,450 $3.55 Million

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.42B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Hodges Capital Management Inc. Portfolio

Follow Hodges Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hodges Capital Management Inc. with notifications on news.